nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Allogeneic Hematopoietic Stem Cell Transplantation Following CAR T Therapy in Relapsed/Refractory Acute Lymphoblastic Leukemia
|
Rafaeli, Natalie |
|
|
25 |
6 |
p. e374-e377 |
artikel |
2 |
CD19 CAR-T With Axicabtagene Ciloleucel in R/R Large B-Cell Lymphoma With/Without Prior Autologous Stem Cell Transplant
|
Chen, David T. |
|
|
25 |
6 |
p. 432-439 |
artikel |
3 |
Characteristics and Survival of Secondary Acute Myeloid Leukemia From Myelodysplastic Syndromes in Older Adults: A Population Analysis
|
Batra, Akshee |
|
|
25 |
6 |
p. e417-e423 |
artikel |
4 |
Editorial Board
|
|
|
|
25 |
6 |
p. A1-A2 |
artikel |
5 |
Enhancing Multiple Myeloma Care: Implementation of Pharmacist-Led Prescribing of Immunomodulatory Drugs in an Academic Medical Setting
|
Indorf, Amy |
|
|
25 |
6 |
p. e424-e434 |
artikel |
6 |
Epidemiology, Treatment Outcomes, and Prognosis of Myelodysplastic Syndromes/Neoplasms in Taiwan: Real-World Insights and Trends
|
Lee, Wan-Hsuan |
|
|
25 |
6 |
p. e336-e347.e14 |
artikel |
7 |
Evaluation of Clinical Characteristics and Prognostic Factors of Early Progressive Disease (EPD) in Newly Diagnosed Multiple Myeloma Patients: Real-World Data of the Greek Myeloma Study Group
|
Katodritou, Eirini |
|
|
25 |
6 |
p. e359-e365 |
artikel |
8 |
Familial Multiple Myeloma: Insights From Epidemiology and Underlying Germline Genetic Predisposition to the Clinic
|
Akkus, Erman |
|
|
25 |
6 |
p. e411-e416 |
artikel |
9 |
Improvements in Outcomes in Older Patients With Mantle Cell Lymphoma Are Associated With Improvements Across Multiple Lines of Therapy
|
Luan, Danny |
|
|
25 |
6 |
p. e383-e392.e1 |
artikel |
10 |
Minimal Residual Disease Testing Infrastructure in Multiple Myeloma: Guidance for Clinical Trial and Routine Practice Use in Canada
|
Mian, Hira S |
|
|
25 |
6 |
p. e404-e410 |
artikel |
11 |
Perspectives on Current Challenges and Emerging Approaches for Lymphoma Management From the First Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Conference
|
Danilov, Alexey V. |
|
|
25 |
6 |
p. e366-e373 |
artikel |
12 |
Prognostic Value of Dynamic Measurable Residual Disease Monitoring by Multiflowcytometry in Elderly Patients With Nonintensively Treated Acute Myeloid Leukemia
|
Sun, Yue |
|
|
25 |
6 |
p. 440-448 |
artikel |
13 |
Real-World Treatment Patterns and Outcomes in Patients With Lenalidomide-Refractory Multiple Myeloma With 1 to 3 Prior Lines: SEER-Medicare Database
|
Dhakal, Binod |
|
|
25 |
6 |
p. e394-e403 |
artikel |
14 |
SOHO State of the Art Updates and Next Questions: Combination Therapy in Chronic Myeloid Leukemia in Chronic Phase
|
Costa, Alessandro |
|
|
25 |
6 |
p. 421-431 |
artikel |
15 |
SOHO State of the Art Updates and Next Questions | Diffuse Large B-Cell Lymphoma in Older Adults: A Comprehensive Review
|
Iyengar, Varun |
|
|
25 |
6 |
p. 395-409 |
artikel |
16 |
SOHO State of the Art Updates and Next Questions | Impact of Biologic Markers on Outcomes With Novel Therapy in Chronic Lymphocytic Leukaemia
|
Varghese, Abraham M |
|
|
25 |
6 |
p. 381-394 |
artikel |
17 |
SOHO State of the Art Updates and Next Questions | Venetoclax + Obinutuzumab Therapy in Chronic Lymphocytic Leukemia
|
Lipsky, Andrew H. |
|
|
25 |
6 |
p. 410-420 |
artikel |
18 |
Spot Urine Protein/Creatinine Ratio as an Alternative to 24-Hour Urine Collection for Measuring Proteinuria in Patients With Multiple Myeloma: A Prospective Study
|
Jamshed, Saad |
|
|
25 |
6 |
p. 449-453 |
artikel |
19 |
Table of Contents
|
|
|
|
25 |
6 |
p. A3-A5 |
artikel |
20 |
The Prospective Use of Avapritinib in Relapsed/Refractory (R/R) RUNX1-RUNX1T1-Positive AML Patients With KIT Mutation
|
Han, Si-Yi |
|
|
25 |
6 |
p. e378-e382 |
artikel |
21 |
Viral and Fungal Infections Early After HLA-Mismatched Hematopoietic Stem Cell Transplantation Using Low-Dose Antithymocyte Globulin in High-Risk Patients With Hematological Malignancies Not in Remission
|
Hirosawa, Makoto |
|
|
25 |
6 |
p. e348-e358 |
artikel |